American Society of Hirudotherapy

Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis.

Comparative study published in Biochemistry (1992)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studySalivary PharmacologyDrug DevelopmentGenomics & ProteomicsSteiner V et al. · Biochemistry, 1992

Abstract

Hirudin from the leech Hirudo medicinalis is a most powerful anticoagulant, and many isoforms have been described. In the present work, the primary structure of two hirudins from the leech Hirudinaria manillensis has been elucidated. The antithrombotic activity is similar to that of H. medicinalis hirudins although the sequence identity is below 60%. Surprisingly, the hirudins were found to be glycosylated at one site. Sugar analysis after methanolysis yielded fucose, galactose, and N-acetylgalactosamine. These results combined with data from matrix-assisted laser desorption ionization mass spectrometry, plasma desorption mass spectrometry, capillary zone electrophoresis, and lectin-binding tests indicate that the sequence is Fuc-Gal beta 1-3GalNAc-(O-threonine). This structure shows an interesting similarity to human blood group H determinants.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAmino Acid SequenceAmino AcidsAnimalsCarbohydrate ConformationGlycosylationHirudinsLeechesMolecular Sequence DataSequence AlignmentSequence Homology, Nucleic AcidStructure-Activity RelationshipThrombin

Summary

Hirudin from the leech Hirudo medicinalis is a most powerful anticoagulant, and many isoforms have been described. In the present work, the primary structure of two hirudins from the leech Hirudinaria manillensis has been elucidated.

Why This Matters for Hirudotherapy

This comparative biochemistry study elucidated the primary structure of two hirudins from the leech Hirudinaria manillensis and found their antithrombotic activity similar to that of Hirudo medicinalis hirudins despite under 60% sequence identity, and unexpectedly showed these hirudins are glycosylated at a single site (Fuc-Gal beta1-3GalNAc on threonine), a structure the authors note resembles human blood-group H determinants. This matters to the leech-secretome story because it documents that potent thrombin-directed anticoagulants are not unique to Hirudo medicinalis but recur across leech species, and it adds a post-translational (glycosylation) dimension to hirudin diversity relevant to understanding and engineering these molecules. As an in-vitro structural and functional characterization it speaks to molecular pharmacology, not to clinical outcomes of hirudotherapy, and the antithrombotic comparison was made at the biochemical level rather than in patients.

Citation

Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis.

Steiner V et al. · Biochemistry, 1992

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.